Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moutih Rafei

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokineMoutih Rafei, Philippe M Campeau, Jian Hui Wu, et al.
Frontiers in Immunology|September 5, 2025
Mesenchymal stromal cells 2.0: thinking outside the boxGabrielle A Mandl, Malak Lahrichi, Perla Matar, et al.
Cells|June 10, 2022
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress ResponseFatemeh Mardani, Wael Saad, Nehme El-Hachem, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2010
A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivoPatrick Williams, Moutih Rafei, Manaf Bouchentouf, et al.
Frontiers in Immunology|February 5, 2021
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity <i>via</i> Cross-Priming of Endogenous Dendritic CellsJean-Pierre Bikorimana, Nehme El-Hachem, Abed El-Hakim El-Kadiry, et al.
Cancer Science|January 30, 2024
An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activityJean-Pierre Bikorimana, Jamilah Abusarah, Marina Gonçalves, et al.
Stem Cell Research & Therapy|January 11, 2022
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cellsNatasha Salame, Jean-Pierre Bikorimana, Nehme El-Hachem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritisMoutih Rafei, Yamina A Berchiche, Elena Birman, et al.
Elife|March 27, 2026
Nociceptor neurons control pollution-mediated neutrophilic asthmaJo-Chiao Wang, Amelia Kulle, Theo Crosson, et al.
Cell Reports|December 11, 2024
Cytokines reprogram airway sensory neurons in asthmaTheo Crosson, Shreyas Bhat, Jo-Chiao Wang, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokineMoutih Rafei, Philippe M Campeau, Jian Hui Wu, et al.
Frontiers in Immunology|September 5, 2025
Mesenchymal stromal cells 2.0: thinking outside the boxGabrielle A Mandl, Malak Lahrichi, Perla Matar, et al.
Cells|June 10, 2022
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress ResponseFatemeh Mardani, Wael Saad, Nehme El-Hachem, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2010
A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivoPatrick Williams, Moutih Rafei, Manaf Bouchentouf, et al.
Frontiers in Immunology|February 5, 2021
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity <i>via</i> Cross-Priming of Endogenous Dendritic CellsJean-Pierre Bikorimana, Nehme El-Hachem, Abed El-Hakim El-Kadiry, et al.
Cancer Science|January 30, 2024
An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activityJean-Pierre Bikorimana, Jamilah Abusarah, Marina Gonçalves, et al.
Stem Cell Research & Therapy|January 11, 2022
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cellsNatasha Salame, Jean-Pierre Bikorimana, Nehme El-Hachem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritisMoutih Rafei, Yamina A Berchiche, Elena Birman, et al.
Elife|March 27, 2026
Nociceptor neurons control pollution-mediated neutrophilic asthmaJo-Chiao Wang, Amelia Kulle, Theo Crosson, et al.
Cell Reports|December 11, 2024
Cytokines reprogram airway sensory neurons in asthmaTheo Crosson, Shreyas Bhat, Jo-Chiao Wang, et al.
Pageof 7